Picture of Parnell Pharmaceuticals Holdings logo

PARNF — Parnell Pharmaceuticals Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Parnell Pharmaceuticals Holdings, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.

2012
June 30th
2013
June 30th
2014
June 30th
2014
December 31st
2015
December 31st
Period Length:12 M12 M12 M6 M12 M
Source:PROSPECTUSPROSPECTUS20-F20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital0.0270.0070.02400.009
Other Operating Cash Flow
Cash from Operating Activities3.56-2.98-11.5-5.42-16.4
Capital Expenditures-5.21-2.96-1.92-1.81-9.55
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items00.5441.4401.67
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-5.21-2.41-0.483-1.81-7.88
Financing Cash Flow Items-0.68-0.68-5.11-0.6120
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.016.1731.9-0.72612.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.6450.78119.9-4.98-10.2